PR Newswire

Martindale Pharma® Launches Prenoxad® Injection for the Emergency Treatment of Opioid Overdose

World's first licensed naloxone product for use by non-healthcare profession individuals in a community setting Prenoxad Injection is a pre-filled syringe containing 1mg/ml naloxone hydrochloride ...
Finanznachrichten

Prenoxad Injection Approved in Five European Countries Opening Way for Pan-European Availability of a Take-home Naloxone Product

- Prenoxad Injection to be Filed for Regulatory Approval in France in Summer 2016 Martindale Pharma, UK-based international specialty pharmaceutical company, today announced the regulatory approval of ...
PharmaTimes

Approvals round-up: 20 May

This week's round-up of drug approvals and HTA news includes: an SMC recommendations for AbbVie's Humira; decentralised approval in five EU countries for Martindale's Prenoxad injection; and an EU ...
Medindia

Martindale Pharma® Launches Prenoxad® Injection for the Emergency Treatment of Opioid Overdose

Prenoxad Injection is a Prescription Only Medicine (POM) containing a solution of naloxone hydrochloride. It is intended for emergency use for the complete or partial reversal of life-threatening ...
PR Newswire

Prenoxad Injection Approved in Five European Countries Opening Way for Pan-European Availability of a Take-home Naloxone Product

Martindale Pharma, UK-based international specialty pharmaceutical company, today announced the regulatory approval of Prenoxad Injection in Sweden, Denmark, Ireland, Finland and Estonia following the ...